Clinical Trial Update: Praziquantel-Pharmacokinetic Study [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study of praziquantel conducted to characterize absorption and metabolism in the context of Schistosomiasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schistosomiasis

Drugs mentioned

• Praziquantel (Praziquantel)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Schistosomiasis | Phase 1 | Status: COMPLETED